$237.88
3M Ago | 1M Ago | Current | |
Buy | 17 | 16 | 16 |
Outperform | 8 | 8 | 8 |
Hold | 8 | 10 | 10 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Alnylam Pharmaceuticals, Inc. (ALNY) is $261.15, offered by 34 analysts offering 12-month price forecasts.
Alnylam Pharmaceuticals, Inc. (ALNY) has a maximum of 0.1 upside potential, based on 34 analysts offering 12-month price forecasts.
Based on 34 analysts tracking and researching Alnylam Pharmaceuticals, Inc. (ALNY), 70.59% have a buy recommendation. Remaining 29.41% have either sell or hold recommendations.
The latest share price of Alnylam Pharmaceuticals, Inc. (ALNY) is $237.88 as of 26/07/2024.
24 of total 34 analysts offering stock ratings for Alnylam Pharmaceuticals, Inc. ALNY have recommended buy rating.